Integrase Inhibitors in Women and Pediatrics | Alberto Chaparro-Sánchez, MD

Mexican HIV Clinical Forum 2018

Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico | Luis Soto-Ramirez, MD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Santiago Pérez Patrigeon, PhD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Samuel Navarro, MD

Mexican HIV Clinical Forum 2018

Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmD

Mexican HIV Clinical Forum 2018

Clinical Update on Integrase Inhibitors: Recent Data | Pablo Tebas, MD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Aurelio Orta. MD

Mexican HIV Clinical Forum 2018

HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhD

Mexican HIV Clinical Forum 2018

Clinical Update on Integrase Inhibitors: Recent Data | Pablo Tebas, MD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Mauro Schechter, MD, PhD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Samuel Navarro, MD

Mexican HIV Clinical Forum 2018

Optimal use of Integrase Inhibitors in Routine Patient Care in Mexico | Luis Soto-Ramirez, MD

Mexican HIV Clinical Forum 2018

Integrase Inhibitors in Women and Pediatrics | Alberto Chaparro-Sánchez, MD

Mexican HIV Clinical Forum 2018

HIV integrase Inhibitors: A novel mechanisms of action | Francisco Flores Murrieta, PhD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Santiago Pérez Patrigeon, PhD

Mexican HIV Clinical Forum 2018

Clinical case presentation | Aurelio Orta. MD

Mexican HIV Clinical Forum 2018

Pharmacological Characteristics and Delivery Options of the Integrase Inhibitors | Courtney Fletcher, PharmD

Mexican HIV Clinical Forum 2018